LBC
JNJ icon

Lowe Brockenbrough & Co’s Johnson & Johnson JNJ Stock Holding History

Lowe Brockenbrough & Co’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Sell
47,943
-1,557
-3% -$363K 0.58% 47
2025
Q4 		$10.2M Buy
49,500
+16
+0% +$3.16K 0.5% 52
2025
Q3 		$9.18M Sell
49,484
-5,909
-11% -$1.01M 0.47% 56
2025
Q2 		$8.46M Sell
55,393
-36,193
-40% -$5.56M 0.48% 58
2025
Q1 		$15.2M Buy
91,586
+3,647
+4% +$571K 1% 25
2024
Q4 		$12.7M Sell
87,939
-6,287
-7% -$974K 0.82% 36
2024
Q3 		$15.3M Sell
94,226
-4,459
-5% -$710K 0.97% 25
2024
Q2 		$14.4M Sell
98,685
-440
-0.4% -$65.4K 0.96% 30
2024
Q1 		$15.7M Buy
99,125
+4,533
+5% +$722K 1.06% 28
2023
Q4 		$14.8M Sell
94,592
-6,091
-6% -$934K 1.15% 20
2023
Q3 		$15.7M Sell
100,683
-6,705
-6% -$1.11M 1.22% 21
2023
Q2 		$17.8M Buy
107,388
+782
+0.7% +$126K 1.34% 17
2023
Q1 		$16.5M Buy
106,606
+1,908
+2% +$308K 1.34% 16
2022
Q4 		$18.5M Sell
104,698
-2,446
-2% -$422K 1.61% 12
2022
Q3 		$17.5M Sell
107,144
-2,868
-3% -$485K 1.69% 10
2022
Q2 		$19.5M Sell
110,012
-971
-0.9% -$173K 1.71% 7
2022
Q1 		$19.7M Buy
110,983
+654
+0.6% +$111K 1.45% 12
2021
Q4 		$18.9M Buy
110,329
+22,160
+25% +$3.63M 1.38% 14
2021
Q3 		$14.2M Buy
88,169
+9,284
+12% +$1.58M 1.11% 20
2021
Q2 		$13M Sell
78,885
-1,795
-2% -$297K 1.17% 26
2021
Q1 		$13.3M Sell
80,680
-3,804
-5% -$616K 1.29% 20
2020
Q4 		$13.3M Sell
84,484
-106
-0.1% -$15.6K 1.44% 13
2020
Q3 		$12.6M Buy
84,590
+275
+0.3% +$40.7K 1.57% 12
2020
Q2 		$11.9M Sell
84,315
-873
-1% -$127K 1.59% 14
2020
Q1 		$11.2M Sell
85,188
-3,337
-4% -$473K 1.84% 10
2019
Q4 		$12.9M Sell
88,525
-3,132
-3% -$425K 1.6% 12
2019
Q3 		$11.9M Sell
91,657
-332
-0.4% -$43.7K 1.59% 13
2019
Q2 		$12.8M Sell
91,989
-5,623
-6% -$778K 1.75% 12
2019
Q1 		$13.6M Sell
97,612
-1,150
-1% -$154K 1.91% 10
2018
Q4 		$12.7M Sell
98,762
-8,380
-8% -$1.17M 2.08% 7
2018
Q3 		$14.8M Sell
107,142
-779
-0.7% -$104K 2.07% 8
2018
Q2 		$13.1M Buy
107,921
+2,076
+2% +$259K 1.92% 8
2018
Q1 		$13.6M Sell
105,845
-1,280
-1% -$173K 2.01% 8
2017
Q4 		$15M Sell
107,125
-1,627
-1% -$227K 2.15% 6
2017
Q3 		$14.1M Sell
108,752
-3,200
-3% -$424K 2.17% 6
2017
Q2 		$14.8M Sell
111,952
-2,411
-2% -$308K 2.33% 5
2017
Q1 		$14.2M Buy
114,363
+1,597
+1% +$191K 2.27% 5
2016
Q4 		$13M Sell
112,766
-4,480
-4% -$517K 2.17% 6
2016
Q3 		$13.8M Sell
117,246
-2,170
-2% -$263K 2.39% 4
2016
Q2 		$14.5M Buy
119,416
+150
+0.1% +$17K 2.52% 3
2016
Q1 		$12.9M Sell
119,266
-1,297
-1% -$134K 2.22% 4
2015
Q4 		$12.4M Sell
120,563
-4,233
-3% -$426K 2.11% 4
2015
Q3 		$11.7M Buy
124,796
+1,580
+1% +$153K 2.04% 5
2015
Q2 		$12M Sell
123,216
-2,786
-2% -$279K 1.93% 6
2015
Q1 		$12.7M Buy
126,002
+1,883
+2% +$191K 2% 4
2014
Q4 		$13M Sell
124,119
-1,279
-1% -$135K 2.06% 5
2014
Q3 		$13.4M Sell
125,398
-7,389
-6% -$766K 2.13% 4
2014
Q2 		$13.9M Sell
132,787
-563
-0.4% -$56.9K 2.22% 4
2014
Q1 		$13.1M Sell
133,350
-1,892
-1% -$175K 2.18% 5
2013
Q4 		$12.4M Sell
135,242
-4,901
-3% -$452K 2.05% 7
2013
Q3 		$12.1M Buy
140,143
+220
+0.2% +$19.7K 2.21% 3
2013
Q2 		$12M Buy
+139,923
New +$11.9M 2.23% 5

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lowe Brockenbrough & Co's JNJ Position: Q1 2026 in Review

Lowe Brockenbrough & Co reduced its Johnson & Johnson (JNJ) stake by 3.1% in Q1 2026, selling an estimated $363K and leaving 47,943 shares worth $11.7M. The position accounts for 0.58% of the portfolio, ranked #47.

Lowe Brockenbrough & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.7M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Lowe Brockenbrough & Co held 47,943 shares of Johnson & Johnson worth $11.7M as of Q1 2026.
  • Lowe Brockenbrough & Co sold 1,557 Johnson & Johnson shares in Q1 2026, an estimated $363K.
  • Johnson & Johnson made up 0.58% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #47 holding.
  • Lowe Brockenbrough & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Johnson & Johnson position peaked at $19.7M in Q1 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.